Globeflex Capital L P trimmed its holdings in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 7.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,328 shares of the company’s stock after selling 2,900 shares during the period. Globeflex Capital L P owned about 0.09% of Phibro Animal Health Corporation worth $1,383,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. State of Alaska Department of Revenue lifted its position in Phibro Animal Health Corporation by 80.9% during the second quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after buying an additional 1,650 shares in the last quarter. Mason Street Advisors LLC lifted its position in Phibro Animal Health Corporation by 7.1% during the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock valued at $122,000 after buying an additional 286 shares in the last quarter. Municipal Employees Retirement System of Michigan lifted its position in Phibro Animal Health Corporation by 3.6% during the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares in the last quarter. KBC Group NV acquired a new position in Phibro Animal Health Corporation during the second quarter valued at approximately $166,000. Finally, Victory Capital Management Inc. lifted its position in Phibro Animal Health Corporation by 79.2% during the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock valued at $129,000 after buying an additional 2,021 shares in the last quarter. 48.06% of the stock is currently owned by hedge funds and other institutional investors.

A number of research analysts have recently commented on the stock. BidaskClub cut shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 23rd. Bank of America Corporation reissued an “underperform” rating and set a $33.00 target price on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Piper Jaffray Companies set a $35.00 target price on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Finally, Credit Suisse Group boosted their target price on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an “outperform” rating in a research report on Thursday, August 31st. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $34.00.

In other news, VP Daniel M. Bendheim sold 1,443 shares of the stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $40.05, for a total value of $57,792.15. Following the completion of the sale, the vice president now directly owns 300 shares of the company’s stock, valued at $12,015. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Richard G. Johnson sold 55,529 shares of the stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $36.30, for a total value of $2,015,702.70. Following the completion of the sale, the chief financial officer now directly owns 15,900 shares of the company’s stock, valued at $577,170. The disclosure for this sale can be found here. Insiders sold 404,448 shares of company stock valued at $14,756,514 over the last three months. 48.09% of the stock is owned by company insiders.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/09/25/globeflex-capital-l-p-sells-2900-shares-of-phibro-animal-health-corporation-pahc.html.

Shares of Phibro Animal Health Corporation (PAHC) opened at 35.40 on Monday. The company has a 50-day moving average of $37.87 and a 200 day moving average of $33.97. Phibro Animal Health Corporation has a 12-month low of $24.83 and a 12-month high of $40.25. The firm has a market capitalization of $1.41 billion, a PE ratio of 21.99 and a beta of 1.36.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a return on equity of 47.88% and a net margin of 8.45%. The company had revenue of $194.84 million during the quarter, compared to analysts’ expectations of $192.47 million. During the same period in the prior year, the business earned $0.32 earnings per share. Phibro Animal Health Corporation’s revenue for the quarter was up 3.0% compared to the same quarter last year. On average, analysts predict that Phibro Animal Health Corporation will post $1.56 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be given a $0.10 dividend. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 annualized dividend and a dividend yield of 1.13%. Phibro Animal Health Corporation’s dividend payout ratio is 24.69%.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.